GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Total Liabilities

Curocell (XKRX:372320) Total Liabilities : ₩44,283.17 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Total Liabilities?

Curocell's Total Liabilities for the quarter that ended in Jun. 2023 was ₩44,283.17 Mil.

Curocell's quarterly Total Liabilities increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩135,585.62 Mil) but then declined from Dec. 2022 (₩135,585.62 Mil) to Jun. 2023 (₩44,283.17 Mil).

Curocell's annual Total Liabilities increased from Dec. 2021 (₩94,399.14 Mil) to Dec. 2022 (₩135,585.62 Mil) but then declined from Dec. 2022 (₩135,585.62 Mil) to Dec. 2023 (₩45,869.85 Mil).

Curocell Total Liabilities Historical Data

The historical data trend for Curocell's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Total Liabilities Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
46,153.39 49,049.64 94,399.14 135,585.62 45,869.85

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Total Liabilities - 135,585.62 44,283.17 45,869.85

Curocell Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Curocell's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3270.412+(41615.313+552.965
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+431.155)
=45,869.85

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=104969.386-59099.54
=45,869.85

Curocell's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9948.815+(33215.451+473.111
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+645.796)
=44,283.17

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=88392.885-44109.711
=44,283.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curocell Total Liabilities Related Terms

Thank you for viewing the detailed overview of Curocell's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Total Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines